US FDA approves Citius therapy to treat rare blood cancer
The U.S. Food and Drug Administration has approved a drug Citius Pharmaceuticals company said Thursday is a therapy for patients with a form of blood cancer who have already undergone at least one course of treatment, a year after the regulator rejected it.
POPULAR POSTS
Putin may discuss Ukraine peace deal with Trump
November 22, 2024
Spain’s vice-president Ribera blames floods on climate change
November 22, 2024
Storm lashes northwestern US, killing two people
November 22, 2024
Iceland volcano erupts for tenth time in three years
November 22, 2024
LIVE STREAM